Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 5855
TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97575(US8470836, 2)
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97581(US8470836, 8)
Affinity DataIC50: 6nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97579(US8470836, 6)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97585(US8470836, 12)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97583(US8470836, 10)
Affinity DataIC50: 14nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97578(US8470836, 5)
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97576(US8470836, 3)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97574(US8470836, 1)
Affinity DataIC50: 36nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97577(US8470836, 4)
Affinity DataIC50: 39nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97587(US8470836, 14)
Affinity DataIC50: 57nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97596(US8470836, 7)
Affinity DataIC50: 63nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97590(US8470836, 17)
Affinity DataIC50: 81nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97582(US8470836, 9)
Affinity DataIC50: 93nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97591(US8470836, 18)
Affinity DataIC50: 159nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97584(US8470836, 11)
Affinity DataIC50: 160nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97586(US8470836, 13)
Affinity DataIC50: 195nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97589(US8470836, 16)
Affinity DataIC50: 197nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97593(US8470836, 20)
Affinity DataIC50: 206nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97592(US8470836, 19)
Affinity DataIC50: 409nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97588(US8470836, 15)
Affinity DataIC50: 2.50E+3nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97595(US8470836, 22)
Affinity DataIC50: 2.50E+3nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 4(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97594(US8470836, 21)
Affinity DataIC50: 2.50E+3nMpH: 7.4 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of inhibitors, using 100 μM Ac-Gly-Pro-AFC at 25° C. in a buffer solution contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97585(US8470836, 12)
Affinity DataIC50: 5.00E+4nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97579(US8470836, 6)
Affinity DataIC50: 7.00E+4nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97581(US8470836, 8)
Affinity DataIC50: 8.00E+4nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97579(US8470836, 6)
Affinity DataIC50: 1.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97585(US8470836, 12)
Affinity DataIC50: 1.10E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97579(US8470836, 6)
Affinity DataIC50: 1.27E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97581(US8470836, 8)
Affinity DataIC50: 1.30E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97578(US8470836, 5)
Affinity DataIC50: 1.61E+5nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97583(US8470836, 10)
Affinity DataIC50: 2.10E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97581(US8470836, 8)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97583(US8470836, 10)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97583(US8470836, 10)
Affinity DataIC50: 4.00E+5nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97575(US8470836, 2)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97575(US8470836, 2)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 2(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97575(US8470836, 2)
Affinity DataIC50: 4.00E+5nMpH: 4.5 T: 2°CAssay Description:Enzymatic reactions were conducted for various concentrations of DPP-IV inhibitors, using 0.018 μg DPP-II and 100 μM Gly-Pro-AFC in a buffer so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97585(US8470836, 12)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 9(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97578(US8470836, 5)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-IX was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-IX inhibit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent

TargetDipeptidyl peptidase 8(Human)
Lg Life Sciences

US Patent
LigandPNGBDBM97578(US8470836, 5)
Affinity DataIC50: 4.00E+5nMpH: 7.5 T: 2°CAssay Description:DPP-VIII was obtained and purified. Using Gly-Pro-AFC as the substrate, DPP-IV inhibitors as set forth in Table 2 below were assayed for DPP-VIII inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2013
Entry Details
US Patent